137 related articles for article (PubMed ID: 1619367)
1. In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis.
Rader DJ; Gregg RE; Meng MS; Schaefer JR; Zech LA; Benson MD; Brewer HB
J Lipid Res; 1992 May; 33(5):755-63. PubMed ID: 1619367
[TBL] [Abstract][Full Text] [Related]
2. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.
Rader DJ; Schäfer J; Lohse P; Verges B; Kindt M; Zech LA; Steinmetz A; Brewer HB
J Clin Invest; 1993 Aug; 92(2):1009-17. PubMed ID: 8349786
[TBL] [Abstract][Full Text] [Related]
3. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
Rader DJ; Castro G; Zech LA; Fruchart JC; Brewer HB
J Lipid Res; 1991 Nov; 32(11):1849-59. PubMed ID: 1770304
[TBL] [Abstract][Full Text] [Related]
4. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
[TBL] [Abstract][Full Text] [Related]
5. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.
Roma P; Gregg RE; Meng MS; Ronan R; Zech LA; Franceschini G; Sirtori CR; Brewer HB
J Clin Invest; 1993 Apr; 91(4):1445-52. PubMed ID: 8473493
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
[TBL] [Abstract][Full Text] [Related]
7. Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes.
Kameyama H; Nakajima H; Nishitsuji K; Mikawa S; Uchimura K; Kobayashi N; Okuhira K; Saito H; Sakashita N
Sci Rep; 2016 Jul; 6():30391. PubMed ID: 27464946
[TBL] [Abstract][Full Text] [Related]
8. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
[TBL] [Abstract][Full Text] [Related]
9. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism.
Ikewaki K; Rader DJ; Zech LA; Brewer HB
J Lipid Res; 1994 Oct; 35(10):1809-19. PubMed ID: 7852858
[TBL] [Abstract][Full Text] [Related]
10. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency.
Santos RD; Schaefer EJ; Asztalos BF; Polisecki E; Wang J; Hegele RA; Martinez LR; Miname MH; Rochitte CE; Da Luz PL; Maranhão RC
J Lipid Res; 2008 Feb; 49(2):349-57. PubMed ID: 17991756
[TBL] [Abstract][Full Text] [Related]
11. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
[TBL] [Abstract][Full Text] [Related]
12. Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.
Kuwabara K; Nishitsuji K; Uchimura K; Hung SC; Mizuguchi M; Nakajima H; Mikawa S; Kobayashi N; Saito H; Sakashita N
J Biol Chem; 2015 Oct; 290(40):24210-21. PubMed ID: 26292220
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia.
McManus DC; Scott BR; Franklin V; Sparks DL; Marcel YL
J Biol Chem; 2001 Jun; 276(24):21292-302. PubMed ID: 11292828
[TBL] [Abstract][Full Text] [Related]
14. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
[TBL] [Abstract][Full Text] [Related]
15. In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects.
Malmendier CL; Lontie JF; Lagrost L; Delcroix C; Dubois DY; Gambert P
J Lipid Res; 1991 May; 32(5):801-8. PubMed ID: 1906522
[TBL] [Abstract][Full Text] [Related]
16. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
Schaefer EJ; Kay LL; Zech LA; Brewer HB
J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
[TBL] [Abstract][Full Text] [Related]
17. HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil.
Kashyap ML; Saku K
Adv Exp Med Biol; 1991; 285():233-6. PubMed ID: 1907081
[TBL] [Abstract][Full Text] [Related]
18. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I.
Emmerich J; Vergès B; Tauveron I; Rader D; Santamarina-Fojo S; Shaefer J; Ayrault-Jarrier M; Thiéblot P; Brewer HB
Arterioscler Thromb; 1993 Sep; 13(9):1299-306. PubMed ID: 8364014
[TBL] [Abstract][Full Text] [Related]
19. Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.
Parolini C; Chiesa G; Zhu Y; Forte T; Caligari S; Gianazza E; Sacco MG; Sirtori CR; Rubin EM
J Biol Chem; 2003 Feb; 278(7):4740-6. PubMed ID: 12471038
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I metabolism in subjects with a PstI restriction fragment length polymorphism of the apoA-I gene and familial hypoalphalipoproteinemia.
Roma P; Gregg RE; Bishop C; Ronan R; Zech LA; Meng MV; Glueck C; Vergani C; Giudici G; Brewer HB
J Lipid Res; 1990 Oct; 31(10):1753-60. PubMed ID: 1981893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
